ATE295727T1 - Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen - Google Patents
Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungenInfo
- Publication number
- ATE295727T1 ATE295727T1 AT02730033T AT02730033T ATE295727T1 AT E295727 T1 ATE295727 T1 AT E295727T1 AT 02730033 T AT02730033 T AT 02730033T AT 02730033 T AT02730033 T AT 02730033T AT E295727 T1 ATE295727 T1 AT E295727T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- diseases
- viral
- piracetam
- certain substituted
- Prior art date
Links
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000004040 pyrrolidinones Chemical class 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01107140 | 2001-03-22 | ||
| PCT/EP2002/003106 WO2002076451A1 (en) | 2001-03-22 | 2002-03-20 | Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE295727T1 true ATE295727T1 (de) | 2005-06-15 |
Family
ID=8176886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02730033T ATE295727T1 (de) | 2001-03-22 | 2002-03-20 | Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040092575A1 (de) |
| EP (1) | EP1392290B1 (de) |
| AT (1) | ATE295727T1 (de) |
| DE (1) | DE60204224T2 (de) |
| ES (1) | ES2242024T3 (de) |
| WO (1) | WO2002076451A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371364B2 (en) | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| PL1667967T3 (pl) * | 2003-09-24 | 2012-11-30 | Ucb Pharma Sa | Sposób wytwarzania pochodnych 2-okso-1-pirolidyny |
| US8420602B2 (en) * | 2004-09-14 | 2013-04-16 | Landon C. G. Miller | Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| US7157421B2 (en) | 2004-12-27 | 2007-01-02 | Miller Landon C G | Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| WO2007012439A1 (en) * | 2005-07-26 | 2007-02-01 | Ucb Pharma, S.A. | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| US20080014271A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| EP2203168B1 (de) * | 2007-09-18 | 2014-07-16 | Stanford University | Zusammensetzungen zur Behandlung einer Infektion mit einem Virus der Flaviviridae-Familie |
| US9101628B2 (en) * | 2007-09-18 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and composition of treating a flaviviridae family viral infection |
| US9149463B2 (en) * | 2007-09-18 | 2015-10-06 | The Board Of Trustees Of The Leland Standford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
| US8940730B2 (en) | 2007-09-18 | 2015-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
| CN102448458B (zh) | 2009-03-18 | 2015-07-22 | 小利兰·斯坦福大学理事会 | 治疗黄病毒科病毒感染的方法和组合物 |
| CN103044306A (zh) * | 2013-01-24 | 2013-04-17 | 吉林化工学院 | 一种新型吡拉西坦药物共晶及其制备方法 |
| CN103073477A (zh) * | 2013-01-24 | 2013-05-01 | 吉林三善恩科技开发有限公司 | 以3,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法 |
| DE102021003961A1 (de) | 2021-07-29 | 2023-02-02 | CARMFI Holding AG | Verfahren zur Herstellung wässriger Arzneimittellösungen mit unterschiedlichen Zusammensetzungen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
| GB8412358D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
-
2002
- 2002-03-20 US US10/472,246 patent/US20040092575A1/en not_active Abandoned
- 2002-03-20 AT AT02730033T patent/ATE295727T1/de not_active IP Right Cessation
- 2002-03-20 ES ES02730033T patent/ES2242024T3/es not_active Expired - Lifetime
- 2002-03-20 WO PCT/EP2002/003106 patent/WO2002076451A1/en not_active Application Discontinuation
- 2002-03-20 DE DE60204224T patent/DE60204224T2/de not_active Expired - Lifetime
- 2002-03-20 EP EP02730033A patent/EP1392290B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20040092575A1 (en) | 2004-05-13 |
| DE60204224T2 (de) | 2006-02-02 |
| EP1392290A1 (de) | 2004-03-03 |
| WO2002076451A1 (en) | 2002-10-03 |
| ES2242024T3 (es) | 2005-11-01 |
| DE60204224D1 (de) | 2005-06-23 |
| EP1392290B1 (de) | 2005-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE295727T1 (de) | Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen | |
| ATE508635T1 (de) | Virusvektoren und ihre verwendung bei therapeutischen methoden | |
| HUS1700003I1 (hu) | Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok | |
| MXPA04002982A (es) | Derivados de pirrolidinona. | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| WO2002062961A3 (en) | Peptide scaffold encapsulation of tissue cells and uses thereof | |
| ATE358669T1 (de) | Pyrazolderivate zur behandlung von hiv | |
| MXPA02006679A (es) | Composicion farmaceutica. | |
| DE602004001857D1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
| DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
| DE69838986D1 (de) | Polypeptide, deren herstellung und verwendung | |
| EP1322307A4 (de) | Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen | |
| DE60137307D1 (de) | Substituierte sapogenine und ihre verwendung | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| WO2001010456A3 (en) | Peptides that block viral infectivity and methods of use thereof | |
| EP1461079A4 (de) | Mutanten von hüllglykoproteinen des human immunodeficiency virus und deren verwendung | |
| DE69825625D1 (de) | Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen | |
| WO1999045098A3 (en) | Delivery or proteins into eukaryotic cells with recombinant yersinia | |
| DE602004017332D1 (de) | Neue kondensierte n-pyrazinyl-sulfonamide und deren verwendung bei der behandlung von chemokinvermittelten krankheiten | |
| EP1663201A4 (de) | Verwendung von neuen 2-oxo-heterozyklischen verbindungen sowie diesen enthaltenden pharmazeutischen zubereitungen | |
| WO2001043693A3 (en) | Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef | |
| DE60130641D1 (de) | Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| ATE414776T1 (de) | Fusionsproteine zur spezifisichen behandlung von krebs und autoimmunkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |